Peptide Stability and Storage: The Lab-Science View
Why peptides break down and how laboratories keep them stable. General lab science, not instructions for personal use.
Scope
This page explains, at a laboratory-science level, why peptides degrade and how researchers generally protect them. It is not a guide to preparing or using peptides in people, and it does not cover reconstitution for injection or dosing. Product-specific storage conditions are set by the manufacturer's labeling and stability data.
Why peptides are unstable
Peptides are susceptible to both chemical and physical degradation 21:
- Hydrolysis: water can slowly break peptide bonds, especially next to aspartic acid residues and at extremes of pH.
- Deamidation: asparagine and glutamine side chains can lose ammonia, changing charge and structure.
- Oxidation: methionine (Met), cysteine (Cys), tryptophan (Trp), and to a lesser degree histidine and tyrosine, react with oxygen and light. Cysteine can also form unintended disulfide bonds.
- Aggregation: peptide molecules can stick together into clumps or fibrils, which reduces activity and can increase immunogenicity. FDA cites aggregation as an immunogenicity concern for several compounding peptides 3.
- Adsorption: dilute peptides can stick to glass or plastic surfaces, lowering the effective concentration.
Lyophilized (freeze-dried) vs. solution
Lyophilized powder is far more stable than peptide in solution because removing water slows hydrolysis, deamidation and microbial growth. Many research peptides are shipped as lyophilized powder for this reason. In solution, degradation reactions proceed faster, and once a container's sterility is compromised microbes can grow. Stability in solution depends heavily on pH, buffer, concentration and the specific sequence.
Temperature
As a general laboratory rule, lower temperatures slow degradation. Lyophilized research peptides are commonly stored frozen (around -20 C, or -80 C for long-term archival storage), while solutions are usually refrigerated short-term or frozen in single-use portions. Brief exposure to room temperature during shipping is often tolerated by dry powder, but heat accelerates every degradation pathway listed above. Approved medicines have specific, tested storage instructions that should be followed exactly.
Moisture, light, and air
- Moisture: lyophilized peptides are often hygroscopic (they absorb water from the air). Labs typically let a cold vial reach room temperature before opening to avoid condensation, and keep containers tightly sealed, sometimes with desiccant.
- Light: Trp- and Tyr-containing peptides can photodegrade; amber vials or dark storage are common.
- Air (oxygen): for Met-, Cys- or Trp-rich peptides, labs may flush vials with an inert gas such as nitrogen or argon.
Freeze-thaw cycles
Repeated freezing and thawing can promote aggregation and degradation, partly because ice formation concentrates the peptide and salts in the remaining liquid. Laboratories commonly divide material into single-use aliquots so that each portion is thawed only once.
Signs of degradation
Visible changes (cloudiness, particles, discoloration, or a powder that has collapsed into a sticky film) suggest degradation or contamination, but many harmful changes, such as oxidation, deamidation, or endotoxin, are invisible. Only analytical testing (HPLC, mass spectrometry, endotoxin assays) can confirm a sample's condition.
Sources
- Muttenthaler M, King GF, Adams DJ, Alewood PF. Trends in peptide drug discovery. Nat Rev Drug Discov. 2021;20:309-325 (PMID 33536635)
- Wang L, et al. Therapeutic peptides: current applications and future directions. Signal Transduct Target Ther. 2022 (PMID 35165272)
- FDA - Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks (current as of April 22, 2026)